The Effect of Antipsychotic Treatment on Cortical Gray Matter Changes in Schizophrenia: Does the Class Matter? A Meta-analysis and Meta-regression of Longitudinal Magnetic Resonance Imaging Studies

Biological Psychiatry

Volumn 78, Issue 6, 2015, Pages 403-412

  Vita, Antonio ^a,b   De Peri, Luca ^a   Deste, Giacomo ^b   Barlati, Stefano ^b   Sacchetti, Emilio ^a,b  

^a UNIVERSITY OF BRESCIA   (Italy)

^b SPEDALI CIVILI   (Italy)

Author keywords

Cortical gray matter; First generation antipsychotics; Magnetic resonance imaging; Schizophrenia; Second generation antipsychotics; Structural brain changes

Indexed keywords

NEUROLEPTIC AGENT;

ARTICLE; BRAIN CORTEX; BRAIN REGION; BRAIN SIZE; CONTROLLED STUDY; DRUG EFFECT; EFFECT SIZE; FOLLOW UP; FRONTAL LOBE; GRAY MATTER; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MEDICAL INFORMATION; META ANALYSIS; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PARIETAL LOBE; PRIORITY JOURNAL; SCHIZOPHRENIA; TEMPORAL LOBE; ADOLESCENT; ADULT; DRUG EFFECTS; FEMALE; MALE; PATHOLOGY; REGRESSION ANALYSIS; YOUNG ADULT;

ADOLESCENT; ADULT; ANTIPSYCHOTIC AGENTS; CEREBRAL CORTEX; FEMALE; GRAY MATTER; HUMANS; LONGITUDINAL STUDIES; MAGNETIC RESONANCE IMAGING; MALE; REGRESSION ANALYSIS; SCHIZOPHRENIA; YOUNG ADULT;

EID: 84929495092     PISSN: 00063223     EISSN: 18732402     Source Type: Journal    
DOI: 10.1016/j.biopsych.2015.02.008     Document Type: Article

References (67)

1. I.C. Wright, S. Rabe-Hesketh, P.W.R. Woodruff, A.S. David, R.M. Murray, and E.T. Bullmore Meta-analysis of regional brain volumes in schizophrenia Am J Psychiatry 157 2000 16 25
2. R. Honea, T.J. Crow, D. Passingham, and C.E. Mackay Regional deficits in brain volume in schizophrenia: A meta-analysis of voxel-based morphometry studies Am J Psychiatry 162 2005 2233 2245
3. S.V. Haijma, N. Van Haren, W. Cahn, P.C. Koolschijn, H.E. Hulshoff Pol, and R.S. Kahn Brain volumes in schizophrenia: A meta-analysis in over 18 000 subjects Schizophr Bull 39 2013 1129 1138
4. A.M. Shepherd, S.L. Matheson, K.R. Laurens, V.J. Carr, and M.J. Green Systematic meta-analysis of insula volume in schizophrenia Biol Psychiatry 72 2012 775 784
5. D.C. Glahn, A.R. Laird, I. Ellison-Wright, S.M. Thelen, J.L. Robinson, J.L. Lancaster, and et al. Meta-analysis of gray matter anomalies in schizophrenia: Application of anatomic likelihood estimation and network analysis Biol Psychiatry 64 2008 774 781
6. A. Vita, L. De Peri, C. Silenzi, and M. Dieci Brain morphology in first-episode schizophrenia: A meta-analysis of quantitative magnetic resonance imaging studies Schizophr Res 82 2006 75 88
7. C. Pantelis, M. Yücel, S.J. Wood, D. Velakoulis, D. Sun, G. Berger, and et al. Structural brain imaging evidence for multiple pathological processes at different stages of brain development in schizophrenia Schizophr Bull 31 2005 672 696
8. M.J. Kempton, D. Stahl, S.C. Williams, and L.E. DeLisi Progressive lateral ventricular enlargement in schizophrenia: A meta-analysis of longitudinal MRI studies Schizophr Res 120 2010 54 62
9. B. Olabi, I. Ellison-Wright, A.M. McIntosh, S.J. Wood, E. Bullmore, and S.M. Lawrie Are there progressive brain changes in schizophrenia? A meta-analysis of structural magnetic resonance imaging studies Biol Psychiatry 70 2011 88 96
10. A. Vita, L. De Peri, G. Deste, and E. Sacchetti Progressive loss of cortical gray matter in schizophrenia: A meta-analysis and meta-regression of longitudinal MRI studies Transl Psychiatry 2 2012 e190
11. P. Fusar-Poli, R. Smieskova, M.J. Kempton, B.C. Ho, N.C. Andreasen, and S. Borgwardt Progressive brain changes in schizophrenia related to antipsychotic treatment? A meta-analysis of longitudinal MRI studies Neurosci Biobehav Rev 37 2013 1680 1691
12. T. Sharma, E. Lancaster, D. Lee, S. Lewis, T. Sigmundsson, N. Takei, and et al. Brain changes in schizophrenia. Volumetric MRI study of families multiply affected with schizophrenia - the Maudsley family study 5 Br J Psychiatry 173 1998 132 138
13. W.F. Baare, C.J. van Oel, H.E. Hulshoff Pol, H.G. Schnack, S. Durston, M.M. Sitskoorn, and R.S. Kahn Volumes of brain structures in twins discordant for schizophrenia Arch Gen Psychiatry 58 2001 33 40
14. T.D. Cannon, P.M. Thompson, T.G. van Erp, A.W. Toga, V.P. Poutanen, M. Huttunen, and et al. Cortex mapping reveals regionally specific patterns of genetic and disease-specific gray-matter deficits in twins discordant for schizophrenia Proc Natl Acad Sci U S A 99 2002 3228 3233
15. R.G. Brans, N.E. van Haren, G.C. van Baal, H.G. Schnack, R.S. Kahn, and H.E. Hulshoff Pol Heritability of changes in brain volume over time in twin pairs discordant for schizophrenia Arch Gen Psychiatry 65 2008 1259 1268
16. N.E. van Haren, F. Rijsdijk, H.G. Schnack, M.M. Picchioni, T. Toulopoulou, M. Weisbrod, and et al. The genetic and environmental determinants of the association between brain abnormalities and schizophrenia: The schizophrenia twins and relatives consortium Biol Psychiatry 71 2012 915 921
17. J.A. Lieberman, G.D. Tollefson, C. Charles, R. Zipursky, T. Sharma, R.S. Kahn, and et al. HGDH Study Group. Antipsychotic drug effects on brain morphology in first-episode psychosis Arch Gen Psychiatry 62 2005 361 370
18. N.E. van Haren, H.E. Hulshoff Pol, H.G. Schnack, W. Cahn, R. Brans, I. Carati, and et al. Progressive brain volume loss in schizophrenia over the course of the illness: Evidence of maturational abnormalities in early adulthood Biol Psychiatry 63 2008 106 113
19. B.C. Ho, N.C. Andreasen, S. Ziebell, R. Pierson, and V. Magnotta Long-term antipsychotic treatment and brain volumes: A longitudinal study of first-episode schizophrenia Arch Gen Psychiatry 68 2011 128 137
20. C. Arango, M. Rapado-Castro, S. Reig, J. Castro-Fornieles, A. González-Pinto, S. Otero, and et al. Progressive brain changes in children and adolescents with first-episode psychosis Arch Gen Psychiatry 69 2012 16 26
21. N.C. Andreasen, D. Liu, S. Ziebell, A. Vora, and B.C. Ho Relapse duration, treatment intensity, and brain tissue loss in schizophrenia: A prospective longitudinal MRI study Am J Psychiatry 170 2013 609 615
22. J. Lieberman, M. Chakos, H. Wu, J. Alvir, E. Hoffman, D. Robinson, and R. Bilder Longitudinal study of brain morphology in first episode schizophrenia Biol Psychiatry 49 2001 487 499
23. W. Cahn, H.E. Hulshoff Pol, E.B. Lems, N.E. van Haren, H.G. Schnack, J.A. van der Linden, and et al. Brain volume changes in first-episode schizophrenia: A 1-year follow-up study Arch Gen Psychiatry 59 2002 1002 1010
24. D.L. Garver, J.A. Holcomb, and J.D. Christensen Cerebral cortical gray expansion associated with two second-generation antipsychotics Biol Psychiatry 58 2005 62 66
25. N.E. van Haren, H.E. Hulshoff Pol, H.G. Schnack, W. Cahn, R.C. Mandl, D.L. Collins, and et al. Focal gray matter changes in schizophrenia across the course of the illness: A 5-year follow-up study Neuropsychopharmacology 32 2007 2057 2066
26. B. Crespo-Facorro, R. Roiz-Santiáñez, R. Pérez-Iglesias, J.M. Pelayo-Terán, J.M. Rodríguez-Sánchez, D. Tordesillas-Gutiérrez, and et al. Effect of antipsychotic drugs on brain morphometry. A randomized controlled one-year follow-up study of haloperidol, risperidone and olanzapine Prog Neuropsychopharmacol Biol Psychiatry 32 2008 1936 1943
27. A. Vita, and L. De Peri The effects of antipsychotic treatment on cerebral structure and function in schizophrenia Int Rev Psychiatry 19 2007 429 436
28. S. Navari, and P. Dazzan Do antipsychotic drugs affect brain structure? A systematic and critical review of MRI findings Psychol Med 39 2009 1763 1777
29. R. Smieskova, P. Fusar-Poli, P. Allen, K. Bendfeldt, R.D. Stieglitz, J. Drewe, and et al. The effects of antipsychotics on the brain: What have we learnt from structural imaging of schizophrenia? - a systematic review Curr Pharm Des 15 2009 2535 2549
30. J. Moncrieff, and J. Leo A systematic review of the effects of antipsychotic drugs on brain volume Psychol Med 40 2010 1409 1422
31. N.E. Van Haren, W. Cahn, H.E. Hulshoff Pol, and R.S. Kahn Confounders of excessive brain volume loss in schizophrenia Neurosci Biobehav Rev 37 2013 2418 2423
32. R.G. Steen, C. Mull, R. McClure, R.M. Hamer, and J.A. Lieberman Brain volume in first-episode schizophrenia: Systematic review and meta-analysis of magnetic resonance imaging studies Br J Psychiatry 188 2006 510 518
33. L.V. Hedges, and I. Holkin Statistical Methods for Meta-Analysis 1985 Academic Press New York
34. M. Egger, G. Davey Smith, M. Schneider, and C Minder Bias in meta-analysis detected by a simple, graphical test BMJ 315 1997 629 634
35. B.H. Ebdrup, A. Skimminge, H. Rasmussen, B. Aggernaes, B. Oranje, H. Lublin, and et al. Progressive striatal and hippocampal volume loss in initially antipsychotic-naive, first-episode schizophrenia patients treated with quetiapine: Relationship to dose and symptoms Int J Neuropsychopharmacol 14 2011 69 82
36. A.L. Sporn, D.K. Greenstein, N. Gogtay, N.O. Jeffries, M. Lenane, P. Gochman, and et al. Progressive brain volume loss during adolescence in childhood-onset schizophrenia Am J Psychiatry 160 2003 2181 2189
37. J.M. Lappin, C. Morgan, S. Chalavi, K.D. Morgan, A.A. Reinders, P. Fearon, and et al. Bilateral hippocampal increase following first-episode psychosis is associated with good clinical, functional and cognitive outcomes Psychol Med 44 2014 1279 1291
38. V. Molina, S. Reig, J. Sanz, T. Palomo, C. Benito, J. Sánchez, and et al. Increase in gray matter and decrease in white matter volumes in the cortex during treatment with atypical neuroleptics in schizophrenia Schizophr Res 80 2005 61 71
39. R. Roiz-Santiáñez, R. Ayesa-Arriola, D. Tordesillas-Gutiérrez, V. Ortiz-García de la Foz, R. Pérez-Iglesias, A. Pazos, and et al. Three-year longitudinal population-based volumetric MRI study in first-episode schizophrenia spectrum patients Psychol Med 44 2013 1591 1604
40. D. Moher, A. Liberati, J. Tetzlaff, D.G. Altman PRISMA Group Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement J Clin Epidemiol 62 2009 1006 1012
41. F. Angelucci, L. Aloe, A. Iannitelli, S.H. Gruber, and A.A. Mathe Effect of chronic olanzapine treatment on nerve growth factor and brain-derived neurotrophic factor in the rat brain Eur Neuropsychopharmacol 15 2005 311 317
42. N.D. Halim, C.S. Weickert, B.W. McClintock, D.R. Weinberger, and B.K. Lipska Effects of chronic haloperidol and clozapine treatment on neurogenesis in the adult rat hippocampus Neuropsychopharmacology 29 2004 1063 1069
43. M.J. Millan N-Methyl-D-aspartate receptors as a target for improved antipsychotic agents: Novel insights and clinical perspectives Psychopharmacology (Berl) 179 2005 30 53
44. A. Post, F. Holsboer, and C. Behl Induction of NF-kappaB activity during haloperidol induced oxidative toxicity in clonal hippocampal cells: Suppression of NF-kappaB and neuroprotection by antioxidants J Neurosci 18 1998 8236 8246
45. A.M. Wright, J. Bempong, M.L. Kirby, R.L. Barlow, and J.R. Bloomquist Effects of haloperidol metabolites on neurotransmitter uptake and release: Possible role in neurotoxicity and tardive dyskinesia Brain Res 788 1998 215 222
46. D.C. Goff, G. Tsai, M.F. Beal, and J.T. Coyle Tardive dyskinesia and substrates of energy metabolism in CSF Am J Psychiatry 152 1995 1730 1736
47. M. Raudenska, J. Gumulec, P. Babula, T. Stracina, M. Sztalmachova, H. Polanska, and et al. Haloperidol cytotoxicity and its relation to oxidative stress Mini Rev Med Chem 13 2013 1993 1998
48. K.-A. Dorph-Petersen, J.N. Pierri, J.M. Perel, Z. Sun, A.R. Sampson, and D.A. Lewis The influence of chronic exposure to antipsychotic medications on brain size before and after tissue fixation: A comparison of haloperidol and olanzapine in macaque monkeys Neuropsychopharmacology 30 2005 1649 1661
49. D.D. Miller, N.C. Andreasen, D.S. O'Leary, K. Rezai, G.L. Watkins, L.L. Ponto, and R.D. Hichwa Effect of antipsychotics on regional cerebral blood flow measured with positron emission tomography Neuropsychopharmacology 17 1997 230 240
50. A.C. Lahti, H.H. Holcomb, M.A. Weiler, D.R. Medoff, K.N. Frey, M. Hardin, and C.A. Tamminga Clozapine but not haloperidol reestablishes normal task-activated rCBF patterns in schizophrenia within the anterior cingulate cortex Neuropsychopharmacology 29 2004 171 178
51. V. Molina, J.D. Gispert, S. Reig, J. Sanz, J. Pascau, A. Santos, and et al. Cerebral metabolism and risperidone treatment in schizophrenia Schizophr Res 60 2003 1 7
52. R. Handley, F.O. Zelaya, A.A. Reinders, T.R. Marques, M.A. Mehta, R. O'Gorman, and et al. Acute effects of single-dose aripiprazole and haloperidol on resting cerebral blood flow (rCBF) in the human brain Hum Brain Mapp 34 2013 272 282
53. A. Ertugrul, B. Volkan-Salanci, K. Basar, K. Karli Oguz, B. Demir, E.L. Ergun, and et al. The effect of clozapine on regional cerebral blood flow and brain metabolite ratios in schizophrenia: Relationship with treatment response Psychiatry Res 174 2009 121 129
54. C.E. Dean Antipsychotic-associated neuronal changes in the brain: Toxic, therapeutic, or irrelevant to the long-term outcome of schizophrenia? Prog Neuropsychopharmacol Biol Psychiatry 30 2006 174 189
55. P.J. Harrison Neurochemical alterations in schizophrenia affecting the putative receptor targets of atypical antipsychotics. Focus on dopamine (D1, D3, D4) and 5-HT2a receptors Br J Psychiatry Suppl 38 1999 12 22
56. G. Letourneau, L.A. Bentaleb, B. Stip, D. Luck, and E. Stip Relationships between brain structure and metabolic changes in schizophrenia patients treated with olanzapine: A voxel-based morphometric study Schizophr Res Treatment 2011 2011 862350
57. K. Maeda, H. Sugino, T. Hirose, H. Kitagawa, T. Nagai, H. Mizoguchi, and et al. Clozapine prevents a decrease in neurogenesis in mice repeatedly treated with phencyclidine J Pharmacol Sci 103 2007 299 308
58. M. Agius, and K.S. Nandra Do atypical antipsychotics promote neurogenesis as a class effect? Psychiatr Danub 24 suppl 1 2012 S191 S193
59. V. Parikh, M.M. Khan, A. Terry, and S.P. Mahadik Differential effects of typical and atypical antipsychotics on nerve growth factor and choline acetyltransferase expression in the cortex and nucleus basalis of rats J Psychiatr Res 38 2004 521 529
60. S. Reig, C. Moreno, D. Moreno, M. Burdalo, J. Janssen, M. Parellada, and et al. Progression of brain volume changes in adolescent onset psychosis Schizophr Bull 35 2009 233 243
61. S. Leucht, M. Samara, S. Heres, M.X. Patel, S.W. Woods, and J.M. Davis Dose equivalents for second-generation antipsychotics: The minimum effective dose method Schizophr Bull 40 2014 314 326
62. B.C. Ho, N.C. Andreasen, P. Nopoulos, S. Arndt, V. Magnotta, and M. Flaum Progressive structural brain abnormalities and their relationship to clinical outcome: A longitudinal magnetic resonance imaging study early in schizophrenia Arch Gen Psychiatry 60 2003 585 594
63. V. Molina, S. Reig, J. Sanz, T. Palomo, C. Benito, J. Sánchez, and et al. Changes in cortical volume with olanzapine in chronic schizophrenia Pharmacopsychiatry 40 2007 135 139
64. T. Takahashi, M. Suzuki, S.Y. Zhou, R. Tanino, K. Nakamura, Y. Kawasaki, and et al. A follow-up MRI study of the superior temporal subregions in schizotypal disorder and first-episode schizophrenia Schizophr Res 119 2010 65 74
65. T. Takahashi, S.J. Wood, Y. Kawasaki, M. Suzuki, D. Velakoulis, and Pantelis Lack of progressive gray matter reduction of the superior temporal subregions in chronic schizophrenia Schizophr Res 117 2010 101 102
66. G. Boonstra, N.E. van Haren, H.G. Schnack, W. Cahn, H. Burger, M. Boersma, and et al. Brain volume changes after withdrawal of atypical antipsychotics in patients with first-episode schizophrenia J Clin Psychopharmacol 31 2011 146 153
67. N.C. Andreasen, P. Nopoulos, V. Magnotta, R. Pierson, S. Ziebell, and B.C. Ho Progressive brain change in schizophrenia: A prospective longitudinal study of first-episode schizophrenia Biol Psychiatry 70 2011 672 679